Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Outlook Showing Expansion To $3.18 Billion By 2030 At 18.9% CAGR

Global Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Over The 2026–2030 Period?

The market for long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing has experienced significant expansion recently. This market is projected to expand from $1.34 billion in 2025 to $1.59 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 18.6%. Historically, this expansion has been driven by several factors, including developments in long-read sequencing technologies, an increase in transcriptome analysis research, greater funding for genomics research, wider acceptance of PacBio and Nanopore platforms, and the broadening of applications in gene expression studies.

The long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market is projected for significant expansion in the coming years, with an anticipated rise to $3.18 billion by 2030, showcasing a compound annual growth rate (CAGR) of 18.9%. This forecasted growth is primarily driven by an increasing demand for precision medicine applications, the greater integration of AI-driven bioinformatics tools, a rise in its utility for rare disease research, the broadening scope of clinical transcriptomics, and the creation of more cost-efficient long-read sequencing workflows. Key developments expected within this period include the increased adoption of single-cell full-length cDNA sequencing, a rising need for high-fidelity long-read platforms, its expanding use in alternative splicing detection, the growth of transcript isoform characterization studies, and the increasing incorporation of advanced library preparation kits.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample_request?id=35483821&type=smp&name=Long-Read%20Full-Length%20Complementary%20Deoxyribonucleic%20Acid%20%28cDNA%29%20Sequencing%20Market%20Report%202026

Which Major Drivers Are Influencing The Expansion Of The Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market?

The increasing emphasis on precision medicine is anticipated to fuel the expansion of the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market moving forward. Precision medicine refers to a medical methodology that tailors prevention and treatment based on an individual’s genetic and molecular attributes. The heightened attention on precision medicine arises from the growing demand for effective treatments for diverse and therapy-resistant ailments. Long-read full-length cDNA sequencing contributes to better clinical decision-making by offering extensive data on transcript isoforms and relevant biomarkers, which allows for more accurate selection of targeted interventions. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the U.S. Food and Drug Administration (FDA) authorized 16 new personalized therapies for rare disease patients, indicating a notable surge from the six approvals observed in 2022. Thus, the intensifying focus on precision medicine is accelerating the growth of the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market.

How Is The Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Broken Down By Segment Categories?

The long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market covered in this report is segmented –

1) By Technology: Pacific Biosciences Single-Molecule Real-Time (PacBio SMRT), Oxford Nanopore, Other Technologies

2) By Product Type: Instruments And Sequencing Platforms, Reagents And Consumables, Library Preparation Kits, Flow Cells And Chips, Data Analysis Software And Bioinformatics Tools

3) By Sample Type: Human, Animal, Plant, Microbial

4) By Application: Transcriptome Analysis, Gene Expression Studies, Alternative Splicing Detection, Fusion Gene Detection, Other Application

5) By End-Users: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Laboratories, Other End Users

Subsegments:

1) By Pacific Biosciences Single-Molecule Real-Time (PacBio SMRT): Sequel System, Sequel II System, RS II System, High-Fidelity Sequencing Systems

2) By Oxford Nanopore: MinION Sequencing Devices, GridION Sequencing Platforms, PromethION Sequencing Platforms, Flongle Sequencing Modules

3) By Other Technologies: Synthetic Long-Read Sequencing, Linked-Read Sequencing, Single-Cell Full-Length cDNA Sequencing, Hybrid Sequencing Approaches

What Trends Are Transforming The Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market?

Leading companies in the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market are concentrating on developing innovative solutions, such as high-fidelity single-molecule sequencing platforms, to enhance transcript accuracy and identify complex RNA isoforms. These high-fidelity single-molecule sequencing platforms are crucial for accurately capturing full-length transcripts and detecting intricate RNA isoforms in a single operation, as they read complete cDNA molecules with low error rates without fragmentation. For instance, in December 2023, Pacific Biosciences of California Inc., a US-based biotechnology company, launched Kinnex RNA kits specifically designed to advance RNA research. These kits leverage high-fidelity single-molecule sequencing platforms technology combined with optimized library preparation workflows to generate highly accurate, long-read transcriptome data. Key features of the Kinnex RNA kits include ultra-long reads that span entire transcripts, superior consensus accuracy, and compatibility with complex RNA samples, enabling researchers to detect alternative splicing, fusion transcripts, and novel isoforms with unprecedented precision. The Kinnex kits are applicable in genomics, transcriptomics, biomarker discovery, and therapeutic target identification, offering a more comprehensive insight into RNA biology compared to conventional methods.

Which Players Are Present In The Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Space?

Major companies operating in the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market are Eurofins Scientific SE, Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., Azenta Life Sciences Inc., BGI Genomics Co. Ltd., Novogene Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., New England Biolabs Inc., Macrogen Inc., DNAnexus Inc., Zymo Research Corporation, CD Genomics Inc., BaseClear B.V., Microsynth AG, Creative Biogene Inc., Nucleome Informatics Inc., Operify Tech Pvt. Ltd., Signios Bio Inc.

Get The Full Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/long-read-full-length-complementary-deoxyribonucleic-acid-cdna-sequencing-market-report

Where Is The Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Most Concentrated Geographically?

North America was the largest region in the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/Customise?id=35483821&name=Long-Read%20Full-Length%20Complementary%20Deoxyribonucleic%20Acid%20%28cDNA%29%20Sequencing%20Market%20Report%202026&type=smp

Browse Through More Reports Similar to the Global Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market 2026, By The Business Research Company

connected health personal medical devices market report 2026

https://www.thebusinessresearchcompany.com/report/connected-health-personal-medical-devices-global-market-report

contract sterilization market report 2026

https://www.thebusinessresearchcompany.com/report/contract-sterilization-global-market-report

orthotic insole 3-d printer market report 2026

https://www.thebusinessresearchcompany.com/report/orthotic-insole-3-d-printer-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model